David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBY
2276
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $1.08M | ﹤0.01% |
72,940
+1,698
| +2% | +$23.9K |
|
2277
CALL
Diageo
DEO
$52.7B
| $1.08M | ﹤0.01% |
+10,000
| New | +$1.06M |
|
2278
CALL
Archer Daniels Midland
ADM
$38.2B
| $1.08M | ﹤0.01% |
29,700
-43,400
| -59% | -$1.51M |
|
2279
3M
MMM
$92.5B
| $1.08M | ﹤0.01% |
7,741
-6,904
| -47% | -$887K |
|
2280
Houlihan Lokey
HLI
$9.02B
| $1.08M | ﹤0.01% |
43,244
+26,257
| +155% | +$638K |
|
2281
CALL
Stryker
SYK
$127B
| $1.07M | ﹤0.01% |
10,000
-10,000
| -50% | -$986K |
|
2282
Waters Corp
WAT
$40.7B
| $1.07M | ﹤0.01% |
8,112
+3,023
| +59% | +$377K |
|
|
IOC
2283
DELISTED
Interoil Corporation
IOC
| $1.07M | ﹤0.01% |
33,522
-32,075
| -49% | -$903K |
|
2284
First Financial Bancorp
FFBC
$3.43B
| $1.07M | ﹤0.01% |
58,639
-5,239
| -8% | -$88.8K |
|
2285
NN Inc
NNBR
$292M
| $1.06M | ﹤0.01% |
77,828
+19,464
| +33% | +$241K |
|
2286
Quantum Corp
QMCO
$882M
| $1.06M | ﹤0.01% |
10,890
-7,594
| -41% | -$731K |
|
|
SSRG
2287
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $1.06M | ﹤0.01% |
107,765
+320
| +0.3% | +$3K |
|
|
OPB
2288
DELISTED
Opus Bank Common Stock
OPB
| $1.06M | ﹤0.01% |
31,169
-12,577
| -29% | -$414K |
|
2289
PUT
United Therapeutics
UTHR
$22.2B
| $1.06M | ﹤0.01% |
9,500
| – | – |
|
2290
Tronox
TROX
$880M
| $1.06M | ﹤0.01% |
165,557
+92,374
| +126% | +$410K |
|
2291
Middleby
MIDD
$5.15B
| $1.06M | ﹤0.01% |
9,895
-8,526
| -46% | -$801K |
|
|
LEAF
2292
DELISTED
Leaf Group Ltd.
LEAF
| $1.05M | ﹤0.01% |
210,853
-17,255
| -8% | -$86.1K |
|
|
CONE
2293
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.05M | ﹤0.01% |
23,052
-7,943
| -26% | -$303K |
|
|
CSW
2294
CSW Industrials
CSW
$5.26B
| $1.05M | ﹤0.01% |
33,263
+7,938
| +31% | +$255K |
|
|
AAV
2295
DELISTED
Advantage Oil & Gas Ltd
AAV
| $1.05M | ﹤0.01% |
190,900
+132,500
| +227% | +$690K |
|
|
VMW
2296
PUT
DELISTED
VMware, Inc
VMW
| $1.05M | ﹤0.01% |
20,000
-17,100
| -46% | -$847K |
|
|
EMKR
2297
DELISTED
Emcore Corp
EMKR
| $1.04M | ﹤0.01% |
20,895
-3,394
| -14% | -$184K |
|
2298
Columbia Banking Systems
COLB
$8.64B
| $1.04M | ﹤0.01% |
34,897
-38,254
| -52% | -$1.12M |
|
2299
TechTarget
TTGT
$281M
| $1.04M | ﹤0.01% |
140,644
+18,349
| +15% | +$136K |
|
|
HZN
2300
DELISTED
Horizon Global Corporation
HZN
| $1.04M | ﹤0.01% |
82,729
+25,401
| +44% | +$252K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.